MarwanNoelSabbaghMD

PubMed

• Perspective: Minimally clinically important "symptomatic" benefit associated with disease modification resulting from anti-amyloid immunotherapy.
  John Alam, Marwan N Sabbagh
  Alzheimer's & Dementia. 2025-01-20
• Blarcamesine for the treatment of Early Alzheimer's Disease: Results from the ANAVEX2-73-AD-004 Phase IIB/III trial.
  Stephen Macfarlane, Timo Grimmer, Ken Teo, Terence J O'Brien, Michael Woodward
  The Journal of Prevention of Alzheimer's Disease. 2025-01-01
• Passive Anti-amyloid Beta Monoclonal Antibodies: Lessons Learned over Past 20 Years.
  Alexandra Wicker, Jahnavi Shriram, Boris Decourt, Marwan Noel Sabbagh
  Neurology and Therapy. 2024-12-01

Journal Articles

• Feasibility Study: Comparison of Frontal Cortex Needle Core Versus Open Biopsy for Detection of Characteristic Proteinopathies of Neurodegenerative Diseases  
  Serrano GE, Intorcia A, Carew J, Chiarolanza G, Hidalgo JA, Sue LI, Dugger BN, Saxon-LaBelle M, Filon J, Scroggins A, Pullen J, Fornwalt BE, Scott S, Sabbagh MN, Adler..., J Neuropathol Exp Neurol, 1/30/2015
• A phase 3 trial of whole brain and regional ß-amyloid pathology as compared to 18F-florbetaben positron emission tomography (PET)  
  Osama Sabri MD, Marwan N. Sabbagh MD, John Seibyl MD, Henryk Barthel MD,Hiroyasu Akatsu MD, Yasuomi Ouchi MD, Kohei Senda MD, Shigeo Murayama MD, Kenji Ishii MD, Masa..., Alzheimers Dement, 1/27/2015
• Phase 3 Trial of [18F]Flutemetamol Imaging and Neuritic Plaque Density  
  Craig Curtis , Jose Gamez , Upinder Singh , Carl Sadowsky , Teresa Villena , Marwan Sabbagh , Thomas Beach , Ranjan Duara , Adam Fleisher , Kirk Frey , Zuzana Walker ,..., JAMA Neurology, 1/26/2015
• Clinical Assessment of Cognitive Decline in Adults with Down Syndrome  
  Sabbagh MN, Edgin JO, Current Alzheimer’s Research, 1/20/2015
• Advanced Glycation Endproduct Modulators: A New Therapeutic Target  
  Walker DG, Lue LF, Paul G, Patel A, Sabbagh MN, Alzheimer’s Disease. Expert Opinion in Investigational Drugs, 1/14/2015
• REM sleep behavior disorder and neuropathology in Parkinson's disease  
  Postuma RB, Adler CH, Dugger BN, Hentz JG, Shill HA, Driver-Dunckley E, Sabbagh MN, Jacobson SA, Belden CM, Sue LI, Serrano G, Beach TG, Mov Disord, 1/12/2015
• Alpha-Synuclein Pathology in Sensory Nerve Terminals of the Upper Aerodigestive Tract of Parkinson's Disease Patients  
  Mu L, Chen J, Sobotka S, Nyirenda T, Benson B, Gupta F, Sanders I, Adler CH, Caviness JN, Shill HA, Sabbagh M, Samanta JE, Sue LI, Beach TG; Arizona Parkinson’s Diseas..., Dysphagia, 1/4/2015
• Neuropsychological Correlates of the Alzheimer’s Questionnaire  
  Budolfson K, Ahmadi MM, Belden CM, Powell J, Davis K, Jacobson SA, Sabbagh MN, J Alzheimers Dis, 1/3/2015
• Sabbagh Neuropathological comparisons of amnestic and nonamnestic mild cognitive impairment  
  Brittany N. Dugger, Kathryn Davis, Michael Malek-Ahmadi, Joseph G. Hentz, Shawn Sandhu, Thomas G. Beach, Charles H. Adler, Richard Caselli, Travis Johnson, Geidy Serra..., BMC Neurol, 1/1/2015
• Deep brain stimulation targeting the fornix for mild Alzheimer Dementia: design of the ADvance randomized controlled trial  
  Kathryn B. Holroyd, Lisa Fosdick, Gwenn Smith, Jeannie-Marie Leoutsakos, Cynthia Munro, Esther Oh, Kristen Drake, Paul B. Rosenberg, William S. Anderson, Stephen Sallo..., Open Access Journal of Clinical Trials, 1/1/2015
• Are Certain Lifestyle Habits Associated with Lower Alzheimer's Disease Risk?  
  Arab L, Sabbagh MN, Alzheimers Dis, 1/1/2015
• Florbetapir PET, FDG PET, and MRI in Down Syndrome Individuals with and without Alzheimer’s Dementia  
  Marwan N. Sabbagh, MD,, Kewei Chen, PhD,, Joseph Rogers, PhD, Adam S. Fleisher, MD,, Carolyn Liebsack, RN, Dan Bandy, MS, Christine Belden, PsyD, Pradeep Thiyyagura, ..., Alzheimers Dement, 1/1/2015
• Sensitivity to Change and Prediction of Global Change for the Alzheimer's Questionnaire (AQ)  
  Michael Malek-Ahmadi, MSPH; Kewei Chen, PhD; Kathryn Davis, BA; Christine .Belden, PsyD; Jessica Powell, PsyD; Sandra A. Jacobson, MD; Marwan N. Sabbagh,MD, Alzheimer's Research & Therapy, 1/1/2015
• A pilot phase IV open-label study investigating the safety and tolerability of Aricept 23mg once daily in patients with moderate to severe AD switched from Exelon patc...  
  Marwan Sabbagh MD; Sandra Jacobson MD; Christine Belden PsyD, Zoran Obradov MD, CCRC, Michael Malek-Ahmadi MSPH, Jessica Powell PsyD, Atul Syal MD, Maninder Kahlon MD..., Annals of Psychiatry and Mental Health, 1/1/2015
• Early investigational drugs targeting tau protein for the treatment of Alzheimer's Disease  
  Anand K, Sabbagh MN, Expert Opinion in Investigational Drugs, 1/1/2015
• Development and validation of the Alzheimer’s Questionnaire (AQ)  
  Malek-Ahmadi M, Sabbagh MN, Journal of Nature and Science, 1/1/2015
• Clinicopathological Outcomes of Prospectively Followed Normal Elderly Brain Bank Volunteers  
  Brittany N. Dugger PhD, Joseph G. Hentz MS, Charles H. Adler MD, PhD, Marwan N. Sabbagh MD, Holly A. Shill MD, Sandra Jacobson MD, John N. Caviness MD, Christine Belde..., J Neuropathol Exp Neurol, 1/30/2014
• Plaques and tangles as well as Lewy-type alpha synucleinopathy are associated with formed visual hallucinations  
  Jacobson SA, Morshed T, Dugger BN, Beach TG, Hentz JG, Adler CH, Shill HA, Sabbagh MN, Belden CM, Sue LI, Caviness JN, Hu C; the Arizona Parkinson's Disease Consortium, Parkinsonism Relat Disord, 1/28/2014
• Longitudinal EEG changes correlate with cognitive measure deterioration in Parkinson’s disease  
  John N. Caviness, Joseph G. Hentz, Christine M. Belden, Holly A. Shill, Erika D. Driver-Dunckley, Marwan N. Sabbagh, Jessica J. Powell, Charles H. Adler, J Parkinsons Dis, 1/24/2014
• Olfactory dysfunction In Incidental Lewy body disease and Parkinson's disease  
  Erika Driver-Dunckley, Charles H. Adler, Joseph G. Hentz, Brittany N. Dugger, Holly A. Shill, John N. Caviness, Marwan N. Sabbagh, Thomas G. Beach, the Arizona Parkins..., Parkinsonism and related disorders, 1/16/2014
• Effect of TTP488 in patients with mild to moderate Alzheimer's disease  
  Aaron H Burstein , Imogene Grimes , Douglas R Galasko , Paul S Aisen , Marwan Sabbagh, Adnan MM Mjalli, BMC Neurology, 1/15/2014
• Positive Florbetapir PET Amyloid Imaging in a Subject with Frequent Cortical Neuritic Plaques and Frontotemporal Lobar Degeneration with TDP43-Positive Inclusions  
  Serrano GE, Sabbagh MN, Sue LI, Hidalgo JA, Schneider JA, Bedell BJ, Van Deerlin VM, Suh E, Akiyama H, Joshi AD, Pontecorvo MJ, Mintun MA, Beach TG, J Alzheimers Dis, 1/13/2014
• Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study  
  P. Murali Doraiswamy, Reisa Sperling, Keith Johnson, Eric Reiman, Terence Wong, Marwan Sabbagh, Carl Sadowsky, Adam Fleisher, Alan Carpenter, Abhinnay Joshi, Ming Lu, ..., Molecular Psychiatry, 1/11/2014
• Clinical Characterization of Mild Cognitive Impairment as a Prodrome of Dementia with Lewy Bodies  
  Belden C, Kahlon VS,Ahmadi MM, Tsai A, Sabbagh MN, American Journal of Alzheimer's Disease and Other Dementias, 1/9/2014
• Follow-up evaluation of cognitive function in the randomized Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT) and its Follow-up Study (ADAPT-FS)  
  ADAPT-FS Research group (Sabbagh MN, Alzheimer’s and Dementia, 1/8/2014
• Join now to see all

Books/Book Chapters

• Geriatric Neurology 
  Chapter: Approach to the Geriatric Neurology Patient: The Neurologic Examination. 
  Page 71 - 84Sabbagh MN, Nair AKEditors: Nair A, Sabbagh MN.Wiley, Oxford2014
• Geriatric Neurology 
  Chapter: Amyloid imaging. 
  Page 162 - 169Nair AK, Sabbagh MNEditors: Nair A, Sabbagh MN.Wiley, Oxford2014
• Frontiers in Drug Design and Discovery 
  Chapter: BACE1 inhibitors: attractive therapeutics for Alzheimer’s disease. 
  Page 518 - 546Decourt B, Macias M, Berk C, Sabbagh M, Adem AEditors: Ur-Rahman A, Choudhary MI.Bentham Science2014
• Geriatric Neurology 
  Chapter: Evidence based pharmacological treatment of dementia. 
  Page 557 - 573Singh J, Sabbagh MN, Nair AKEditors: Nair A, Sabbagh MN.Wiley, Oxford2014
• Encyclopedia of Quality of Life and Well-Being Research. 
  Chapter: Global Deterioration Scale (Individuals). 
  Page 2562 - 2564Belden CM, Burciu C, Sabbagh MEditors: Michalos AC.Springer, Dordrecht, Netherlands2014
• The Alzheimer's Prevention Cookbook: Recipes to Boost Brain Health. 
  Sabbagh M, MacMillan BTenSpeed Press, Emeryville, CA2012
• Palliative Care For Advanced Alzheimer's and Dementia: Guidelines and Standards for Evidence Based Care 
  Editors: Martin G, Sabbagh MN.Springer Publishing Company, New York, NY2010
• The Alzheimer’s Answer: Reduce Your Risk and Keep Your Brain Healthy 
  Sabbagh MNJohn Wiley and Sons, Hoboken, NJ2010
• Principles and Practice of Geriatric Psychiatry 
  Chapter: Staging dementia. 
  Page 162 - 169Reisberg, B., Jamil, I.A., Khan, S., Monteiro, I., Torossian, C., Ferris, S., Sabbagh, M., Gauthier, S., Auer, S., Shulman, M.B., Kluger, A., Franssen, E., and Wegiel, J.Editors: M. T. Abou-Saleh, C. Katona, and A. Kumar.Wiley-Blackwell, Chichester, EnglandEdition 3rd,2010
• Staging in Severe Dementia 
  Chapter: Chapter 8: Clinical Features of Severe Dementia 
  Barry Reisberg, Jerzy Wegiel, Emile Franssen, Sridhar Kadiyala, Stefanie Auer, Liduïn Souren, Marwan Sabbagh and James GolombEditors: Burns and Winblad.John Wiley and Sons, Hoboken, NJ2010
• Alzheimer: Guia practica: Respuestas a las cuestiones fundamentales, desde su diagnostico hsta como se aplica el tratamiento (Spanish Edition) 
  Sabbagh MNRobinBooks, Barcelona, Spain2010
• The Alzheimer’s Answer: Reduce Your Risk and Keep Your Brain Healthy 
  Sabbagh MNJohn Wiley and Sons, Hoboken, NJ2008
• Chemistry and Molecular Aspects of Drug Design and Action 
  Chapter: Inflammatory mechanisms in Alzheimer's disease and other neurodegenerative disorders. 
  Page 3 - 12Rogers J; Beach T; Li R; Liang Z; Lue, L.-F; Roher A; Sabbagh M; Shen Y; Strohmeyer R; Walker DEditors: Kourounakis and Rekka.CRC Press, Boca Raton, FL2007
• Palliative Care for Advanced Dementia: Guidelines and Standards 
  Chapter: Appropriate use of medications in advanced dementia. 
  Page 40 - 51McCarthy M, Gallagher M, Sabbagh MEditors: Long C.Alzheimer’s Association Desert Southwest Chapter, Phoenix, AZ2006
• Severe Dementia 
  Chapter: Clinical features of severe dementia-staging. 
  Page 95 - 127Reisberg B, Weigel J, Franssen E, Kadiyala S, Auer S, Souren L, Sabbagh M, Golomb JEditors: Burns A, Winblad B.John Wiley and Sons, Hoboken, NJ2006
• Alzheimer’s Disease and Related Disorders Annual 5 
  Chapter: Cholesterol, copper, and statin therapy in AD. 
  Page 89 - 110Sparks DL, Petanceska S, Sabbagh M, Connor D, Soares H, Adler C, Lopez J, Ziolowski C, Lochhead J, Browne PEditors: Gauthier S, Schelten P, Cummings J.Taylor and Francis, London2005
• Adult Crying :A Biopsychosocial Approach 
  Chapter: M Vingerhoets, 
  Shaibani AT, Sabbagh MN, Khan B. Pathological Human Crying. In Ad J.J.MEditors: Randolph R. Cornelius.Brunner-Routledge, East Sussex, United Kingdom2002
• Drug Discovery and Drug Development for Alzheimer’s Disease 
  Chapter: The Alzheimer's disease atorvastatin treatment trial: scientific basis and position on the use of the HMG-CoA reductase inhibitors (statins) that do or do not cross the blood-brain barrier. 
  Page 244 - 252Sparks DL, Connor DJ, Browne PJ, Wasser DR, Lopez JE, Sabbagh MNEditors: Fillit H., O’Connell AW.Springer Publishing Company, New York, NY2002
• Current Neurology 
  Chapter: Oral tolerance therapy of autoimmune disease. 
  Page 165 - 189Smith RG, Sabbagh M, White P, Brod SEditors: Appel SH.Mosby, New York, NY1996
• Geriatric Neurology 
  Editors: Nair A, Sabbagh MN.Wiley, Oxford, United Kingdom1996
• Join now to see all